Tirzepatide Dosage Guide

Complete guide to Tirzepatide dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Start at 2.5mg weekly, titrate every 4 weeks through 5mg, 7.5mg, 10mg, 12.5mg, to maximum 15mg weekly. Full titration takes approximately 20 weeks.

Administration Method

Subcutaneous injection once weekly. Rotate injection sites. Slower titration may help reduce GI side effects.

Side Effects to Monitor

Similar to semaglutide: nausea, diarrhea, vomiting, constipation, abdominal pain, decreased appetite. Generally improve with continued use.

Safety Considerations & Risks

Same thyroid cancer warnings as GLP-1 agonists. Risk of pancreatitis, gallbladder disease, hypoglycemia when combined with insulin or sulfonylureas.